Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

NRx Pharmaceuticals Announces Findings In Phase 2b/3 Clinical Trial Of NRX-101 vs. Lurasidone For Treatment Of Suicidal Bipolar Depression, Says Demonstrated A 'promising, though not yet statistically significant 33% reduction in suicidality together with a 70% reduction' In Symptoms Of Akathisia

Author: Benzinga Newsdesk | April 30, 2024 08:37am

Posted In: NRXP